These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 27357223)

  • 1. Molecular mechanisms in lithium-associated renal disease: a systematic review.
    Rej S; Pira S; Marshe V; Do A; Elie D; Looper KJ; Herrmann N; Müller DJ
    Int Urol Nephrol; 2016 Nov; 48(11):1843-1853. PubMed ID: 27357223
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lithium and nephrotoxicity: Unravelling the complex pathophysiological threads of the lightest metal.
    Davis J; Desmond M; Berk M
    Nephrology (Carlton); 2018 Oct; 23(10):897-903. PubMed ID: 29607573
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting renal purinergic signalling for the treatment of lithium-induced nephrogenic diabetes insipidus.
    Kishore BK; Carlson NG; Ecelbarger CM; Kohan DE; Müller CE; Nelson RD; Peti-Peterdi J; Zhang Y
    Acta Physiol (Oxf); 2015 Jun; 214(2):176-88. PubMed ID: 25877068
    [TBL] [Abstract][Full Text] [Related]  

  • 4. P2Y12 Receptor Localizes in the Renal Collecting Duct and Its Blockade Augments Arginine Vasopressin Action and Alleviates Nephrogenic Diabetes Insipidus.
    Zhang Y; Peti-Peterdi J; Müller CE; Carlson NG; Baqi Y; Strasburg DL; Heiney KM; Villanueva K; Kohan DE; Kishore BK
    J Am Soc Nephrol; 2015 Dec; 26(12):2978-87. PubMed ID: 25855780
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence and correlates of renal disease in older lithium users: a population-based study.
    Rej S; Shulman K; Herrmann N; Harel Z; Fischer HD; Fung K; Gruneir A
    Am J Geriatr Psychiatry; 2014 Nov; 22(11):1075-82. PubMed ID: 24566239
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Altered expression of COX-1, COX-2, and mPGES in rats with nephrogenic and central diabetes insipidus.
    Kotnik P; Nielsen J; Kwon TH; Krzisnik C; Frøkiaer J; Nielsen S
    Am J Physiol Renal Physiol; 2005 May; 288(5):F1053-68. PubMed ID: 15644490
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dysregulation of renal aquaporins and epithelial sodium channel in lithium-induced nephrogenic diabetes insipidus.
    Nielsen J; Kwon TH; Christensen BM; Frøkiaer J; Nielsen S
    Semin Nephrol; 2008 May; 28(3):227-44. PubMed ID: 18519084
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Atorvastatin in the treatment of Lithium-induced nephrogenic diabetes insipidus: the protocol of a randomized controlled trial.
    Fotso Soh J; Torres-Platas SG; Beaulieu S; Mantere O; Platt R; Mucsi I; Saury S; Renaud S; Levinson A; Andreazza AC; Mulsant BH; Müller D; Schaffer A; Dols A; Cervantes P; Low NC; Herrmann N; Christensen BM; Trepiccione F; Rajji T; Rej S
    BMC Psychiatry; 2018 Jul; 18(1):227. PubMed ID: 30012135
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic background determines renal response to chronic lithium treatment in female mice.
    de Groot T; Doty R; Damen L; Baumgarten R; Bressers S; Kraak J; Deen PMT; Korstanje R
    Physiol Genomics; 2021 Sep; 53(9):406-415. PubMed ID: 34378418
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Persistent nephrogenic diabetes insipidus following lithium therapy.
    Thompson CJ; France AJ; Baylis PH
    Scott Med J; 1997 Feb; 42(1):16-7. PubMed ID: 9226773
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Psychotropic Drugs and Adverse Kidney Effects: A Systematic Review of the Past Decade of Research.
    Damba JJ; Bodenstein K; Lavin P; Drury J; Sekhon H; Renoux C; Trinh E; Rej S; Greenway KT
    CNS Drugs; 2022 Oct; 36(10):1049-1077. PubMed ID: 36161425
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes of rat kidney AQP2 and Na,K-ATPase mRNA expression in lithium-induced nephrogenic diabetes insipidus.
    Laursen UH; Pihakaski-Maunsbach K; Kwon TH; Østergaard Jensen E; Nielsen S; Maunsbach AB
    Nephron Exp Nephrol; 2004; 97(1):e1-16. PubMed ID: 15153756
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanisms of prolonged lithium therapy-induced nephrogenic diabetes insipidus.
    Behl T; Kotwani A; Kaur I; Goel H
    Eur J Pharmacol; 2015 May; 755():27-33. PubMed ID: 25746463
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Indomethacin treatment in amphotericin B induced nephrogenic diabetes insipidus.
    Höhler T; Teuber G; Wanitschke R; Meyer zum Büschenfeld KH
    Clin Investig; 1994 Oct; 72(10):769-71. PubMed ID: 7865979
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nrf2 activation protects against lithium-induced nephrogenic diabetes insipidus.
    Jobbagy S; Vitturi DA; Salvatore SR; Pires MF; Rowart P; Emlet DR; Ross M; Hahn S; St Croix C; Wendell SG; Subramanya AR; Straub AC; Tan RJ; Schopfer FJ
    JCI Insight; 2020 Jan; 5(1):. PubMed ID: 31941842
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acetazolamide Attenuates Lithium-Induced Nephrogenic Diabetes Insipidus.
    de Groot T; Sinke AP; Kortenoeven ML; Alsady M; Baumgarten R; Devuyst O; Loffing J; Wetzels JF; Deen PM
    J Am Soc Nephrol; 2016 Jul; 27(7):2082-91. PubMed ID: 26574046
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hydrochlorothiazide attenuates lithium-induced nephrogenic diabetes insipidus independently of the sodium-chloride cotransporter.
    Sinke AP; Kortenoeven ML; de Groot T; Baumgarten R; Devuyst O; Wetzels JF; Loffing J; Deen PM
    Am J Physiol Renal Physiol; 2014 Mar; 306(5):F525-33. PubMed ID: 24352504
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lithium in the Kidney: Friend and Foe?
    Alsady M; Baumgarten R; Deen PM; de Groot T
    J Am Soc Nephrol; 2016 Jun; 27(6):1587-95. PubMed ID: 26577775
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lithium-induced nephrogenic diabetes insipidus: new clinical and experimental findings.
    Trepiccione F; Christensen BM
    J Nephrol; 2010; 23 Suppl 16():S43-8. PubMed ID: 21170888
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lithium, Stress, and Resilience in Bipolar Disorder: Deciphering this key homeostatic synaptic plasticity regulator.
    Machado-Vieira R
    J Affect Disord; 2018 Jun; 233():92-99. PubMed ID: 29310970
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.